SC501 to target CSC
- July 25, 2022
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
SC501 to target CSC
Subject: Science and Technology
Section: Biotechnology
Context: A ‘small molecule drug’ that messes with the mechanism of cancer spread has been discovered.
Content:
- Stem cells from cord blood if preserved, can be used to regenerate body parts such as a damaged organ or a broken bone.
- CSC (cancer stem cells) are similar — they help in generating cancer cells. Drugs find it hard to eliminate CSC, because they proliferate rapidly. That’s why many cancer patients get cured and then have a relapse.
- So, two medical researchers have discovered a ‘small molecule drug’, which they call SC501, to target CSC.
Concept:
Small Molecule Drugs
- ‘Small molecule drugs’ are a class of drugs that can easily enter a cell (and thus helpful in targeted therapies).
- The uniqueness of small molecule SC501, is, rather than attacking CSC, it guns down the wnt pathways to inhibit the growth of cancer cells.
- In other words, the small molecule is a ‘wnt inhibitor’; by destroying a feature specific to CSC, namely the ‘wnt pathway’, the molecule prevents the stem cells from increasing their tribe.
- In addition, the SC501 starves cancer cells of bloodby preventing angiogenesis or development of new blood vessels that supply to them. This it does by blocking a protein responsible for angiogenesis.
- It is also called as “magic molecule” because it can potentially be used in the treatment of many other diseases, such as osteoporosis, diabetes and even neuro-degenerative ailments.
Wnt signaling pathway
|
To know about Stem Cells and Cord Blood, refer: https://optimizeias.com/stem-cell-therapy-2/